Patents by Inventor Mary E. Ewashysyn

Mary E. Ewashysyn has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Nucleic acid respiratory syncytial virus vaccines
    Patent number: 6019980
    Abstract: Vectors containing a nucleotide sequence coding for an F protein of respiratory syncytial virus (RSV) and a promoter for such sequence, preferably a cytomegalovirus promoter, are described. Such vectors also may contain a further nucleotide sequence located adjacent to the RSV F protein encoding sequence to enhance the immunoprotective ability of the RSV F protein when expressed in vivo. Such vectors may be used to immunize a host, including a human host, by administration thereto. Such vectors also may be used to produce antibodies for detection of RSV infection in a sample.
    Type: Grant
    Filed: June 7, 1995
    Date of Patent: February 1, 2000
    Assignee: Connaught Laboratories Limited
    Inventors: Xiaomao Li, Mary E. Ewashysyn, Michel H. Klein
  • Nucleic acid respiratory syncytial virus vaccines
    Patent number: 5880104
    Abstract: Vectors containing a nucleotide sequence coding for an F protein of respiratory syncytial virus (RSV) and a promoter for such sequence, preferably a cytomegalovirus promoter, are described. Such vectors also may contain a further nucleotide sequence located adjacent to the RSV F protein encoding sequence to enhance the immunoprotective ability of the RSV F protein when expressed in vivo. Such vectors may be used to immunize a host, including a human host, by administration thereto. Such vectors also may be used to produce antibodies for detection of RSV infection in a sample.
    Type: Grant
    Filed: May 1, 1997
    Date of Patent: March 9, 1999
    Assignee: Connaught Laboratories Limited
    Inventors: Xiaomao Li, Mary E. Ewashysyn, Michel H. Klein